Search

everythinglearnresearchcommunity

for

Search:↓

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

Men and women in infertile couples feel using donor sperm may cause more stress and marital issues than using donor eggs.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Acne is strongly linked to high BMI, hair loss, menstrual issues, family history, and eating too many sweets and fatty foods, but not to excessive hair growth.

Lower hair copper and copper-to-zinc ratio are linked to more severe coronary artery disease.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Prolactin levels and gene polymorphism are not linked to vitiligo severity but are related to BMI.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Obesity is linked to skin conditions like acanthosis nigricans and skin tags, which may indicate high insulin levels.

Low HDL-C, uric acid, and 25-hydroxyvitamin D are risk factors for early-onset male hair loss.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Obesity is linked to more severe lower urinary tract symptoms.

Evaluating various physical and health factors helps diagnose polycystic ovarian syndrome (PCOS).

Women with irregular periods should be checked for PCOS and treated early to prevent complications, with birth control pills helping to manage symptoms.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.